Resumen de acción SYK
Stryker Corporation opera como empresa de tecnología médica.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Recompensas
Análisis de riesgos
Narratives
BetaNarratives bring a range of perspectives from our community.
Warren
Based on Analyst Price Targets
Price at publication US$355.64
View narrative
Updated
1
Competidores de Stryker Corporation
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$329.28 |
| 52 Week High | US$361.41 |
| 52 Week Low | US$249.98 |
| Beta | 0.91 |
| 1 Month Change | -5.85% |
| 3 Month Change | -2.88% |
| 1 Year Change | 15.29% |
| 3 Year Change | 34.53% |
| 5 Year Change | 77.35% |
| Change since IPO | 60,690.12% |
Noticias y actualizaciones recientes
Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 02
We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease
Apr 29Stryker: A Great Company At An Expensive Price
Apr 05Recent updates
Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 02We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease
Apr 29Stryker: A Great Company At An Expensive Price
Apr 05Stryker's (NYSE:SYK) Dividend Will Be $0.80
Mar 26Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Mar 25Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns
Mar 14At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?
Feb 21Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Feb 10Stryker: A Dividend Growth Powerhouse I'd Like To Own
Feb 02Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly
Jan 24Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today
Jan 02Stryker: Mako Shoulder And Spine Launches Are On The Way
Dec 31Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 22Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 08Why Stryker Is An Awesome Healthcare Compounder
Nov 30Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?
Nov 10Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital
Oct 19Stryker: Don't Buy This Dividend Champion (Yet)
Oct 13Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Oct 08Is Stryker (NYSE:SYK) A Risky Investment?
Sep 26Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology
Aug 22Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital
Jul 18Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price
Jul 06These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well
Jun 17Stryker: Good Prospects
Jun 14With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case
May 24Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?
May 01Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital
Apr 18Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)
Apr 06Is Stryker (NYSE:SYK) Using Too Much Debt?
Feb 27Stryker: Typically Excellent, Typically Expensive
Feb 16Stryker Has A Slowing FCF Conversion And No Plans Of Share Buyback
Feb 07If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity
Feb 02Stryker Non-GAAP EPS of $3.00 beats by $0.16, revenue of $5.2B beats by $230M
Jan 31Stryker initiated at sector weight by KeyBanc on limited upside potential
Jan 25Stryker: Excellent Recent And Continuing Performance
Jan 09Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital
Jan 08At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?
Dec 26Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's
Dec 14Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)
Dec 12Rentabilidad de los accionistas
| SYK | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 0.4% | 0.2% | 3.3% |
| 1Y | 15.3% | -1.9% | 25.0% |
Rentabilidad vs. Industria: SYK superó al sector US Medical Equipment , que obtuvo un rendimiento del -2% el año pasado.
Rentabilidad vs. Mercado: SYK obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| SYK volatility | |
|---|---|
| SYK Average Weekly Movement | 2.3% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: SYK no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de SYK (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1941 | 52,000 | Kevin Lobo | www.stryker.com |
Stryker Corporation es una empresa de tecnología médica. La empresa opera a través de dos segmentos, MedSurg y Neurotecnología, y Ortopedia y Columna Vertebral. El segmento de Ortopedia y Columna vertebral suministra implantes para su uso en sustituciones articulares totales, como cadera, rodilla y hombro, y cirugías de traumatismos y extremidades.
Resumen de fundamentos de Stryker Corporation
| Estadísticas fundamentales de SYK | |
|---|---|
| Capitalización bursátil | US$126.53b |
| Beneficios(TTM) | US$3.36b |
| Ingresos (TTM) | US$20.96b |
37.3x
Ratio precio-beneficio (PE)6.0x
Ratio precio-ventas (PS)¿Está SYK sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de SYK | |
|---|---|
| Ingresos | US$20.96b |
| Coste de los ingresos | US$7.55b |
| Beneficio bruto | US$13.42b |
| Otros gastos | US$10.05b |
| Beneficios | US$3.36b |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 8.82 |
| Margen bruto | 63.99% |
| Margen de beneficio neto | 16.03% |
| Ratio deuda/patrimonio | 67.1% |
¿Cómo se ha desempeñado SYK a largo plazo?
Ver rendimiento histórico y comparativa